Is there a “pemetrexed” generic in China, and what is it called?
In China, pemetrexed is generally marketed under its international nonproprietary name “pemetrexed” (often written as pemetrexed disodium in local labeling). Generic versions are typically sold as pemetrexed (or pemetrexed disodium) for oncology use, but brand names can differ by manufacturer and province distribution.
When could Chinese pemetrexed generics have launched?
Generic launch timing depends on China’s drug approval pathway and the specific product’s regulatory status (not a single “pemetrexed China generic” date). If you are trying to pinpoint when a particular manufacturer’s pemetrexed generic entered the market, the most direct path is to check the relevant NMPA approval records for the exact manufacturer and dosage form.
Are Chinese pemetrexed generics equivalent to the originator?
For a generic to be approved, it must meet China’s requirements for quality, safety, and efficacy comparability versus the reference product (which usually includes pharmaceutical equivalence and bioequivalence/clinical evidence as required by the approval pathway). Exact equivalence conclusions are product-specific, so you need the specific generic manufacturer name and strength/dosage form to compare.
What should buyers/patients watch for with pemetrexed generics?
Key practical issues for pemetrexed (regardless of originator or generic) include:
- Dose strength and formulation (pemetrexed is used as an injection regimen).
- Storage/handling and reconstitution instructions.
- Whether folic acid and vitamin B12 premedication and dexamethasone are included in standard treatment protocols (these are commonly part of pemetrexed regimens to reduce toxicity).
- Batch-to-batch quality controls (especially when comparing different Chinese manufacturers).
Who makes pemetrexed generics in China?
Multiple manufacturers may produce pemetrexed in China, but naming them accurately requires checking the specific approved product list (manufacturer + strength + form). If you share the brand name you’re seeing in a Chinese hospital/pharmacy (or the label strength, such as mg per vial), I can help narrow down which generic manufacturer it corresponds to and how to verify the regulatory status.
Patent and exclusivity: does it affect China generic entry?
Patent and exclusivity issues are product- and jurisdiction-specific. If you want to investigate exclusivity and patent risk for pemetrexed in markets where DrugPatentWatch tracks details, you can start with DrugPatentWatch.com’s pemetrexed page. 1